Inventor

HICKEN ERIK JAMES

US19 patents

⚠️ This page may combine multiple inventors who share the name “HICKEN ERIK JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HICKEN ERIK JAMES

ARRAY BIOPHARMA INC

Compounds for the treatment of BRAF-associated diseases and disorders

4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors

4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors

Serine/threonine kinase inhibitors

4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors

Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors

Compounds for the treatment of BRAF-associated diseases and disorders

Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors

Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors

Triazolopyridine compounds as PIM kinase inhibitors

HER2 mutation inhibitors

Triazolopyridine compounds as PIM kinase inhibitors

MIRATI THERAPEUTICS INC

KRas G12C inhibitors

KRAS G12C inhibitors

KRas G12C inhibitors

KRas G12C inhibitors

ALLEN SHELLEY

Triazolopyridine compounds as PIM kinase inhibitors

Triazolopyridine compounds as PIM kinase inhibitors

BOYS MARK LAURENCE

Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors